Bicycle Therapeutics PLC
NASDAQ:BCYC
Bicycle Therapeutics PLC
NASDAQ:BCYC
Price:
21.36 USD
-3.7%
Market Closed
Updated:
May 18, 2024
Bicycle Therapeutics PLC
Tax Provision
|
Bicycle Therapeutics PLC
Tax Provision Peer Comparison
Comparables:
CNTA
EXAI
AUTL
IMCR
GNS
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Tax Provision
-$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Tax Provision
$25.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Tax Provision
£16.1m
|
CAGR 3-Years
82%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Tax Provision
$19k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Tax Provision
£5.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Tax Provision
-£8.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
See Also
What is Bicycle Therapeutics PLC's Tax Provision?
Tax Provision
-1.7m
USD
-1.7m
USD
Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Tax Provision amounts to -1.7m USD.
What is Bicycle Therapeutics PLC's Tax Provision growth rate?
Tax Provision CAGR 5Y
-85%
-85%
You don't have any saved screeners yet
